Option Bears Feel the Sting of Bristol-Myers Squibb Company (BMY) Rally

Short-term Bristol-Myers Squibb Co (BMY) traders have rarely been as put-heavy as they are now

Jan 12, 2015 at 11:06 AM
facebook twitter linkedin


Bristol-Myers Squibb Co (NYSE:BMY) is up 4.4% at $62.98 -- and earlier tagged a fresh 14-year peak of $64.44 -- on news the company's lung cancer drug, Opdivo, met the endpoint goals of its late-stage trial. Today's price action is being met with a rush of call activity in the equity's options pits, with the contracts trading at nearly six times the average intraday pace -- a scenario that runs counter to the withstanding trend.

Specifically, the equity's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.60 ranks in the bearishly skewed 67th annual percentile. Even more telling is BMY's Schaeffer's put/call open interest ratio (SOIR) of 1.21, which ranks just 4 percentage points from a 52-week peak. Simply stated, short-term speculators have rarely been as put-skewed toward BMY as they are now.

Technically speaking, BMY has been in rally mode since hitting its most recent low of $47.54 in mid-October, with the shares up more than 32%. Therefore, it's entirely possible that a portion of the recent put buying is a result of shareholders protecting their paper profits against a pullback. Regardless, the equity's near-term options are currently pricing in lofty volatility expectations, per BMY's Schaeffer's Volatility Index (SVI) of 38%, which ranks higher than all similar readings taken in the past year.

Should Bristol-Myers Squibb Co (NYSE:BMY) extend its positive momentum, a round of upgrades and/or price-target hikes could help fuel the stock's fire. At present, 47% of covering analysts maintain a "hold" or "strong sell" suggestion, while the average 12-month price target of $57.21 stands at a discount to current trading levels.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners